Peptor: Taking a SCAPL to large molecules By Rosy Guerra
Senior editor

While large peptides and proteins are essential to normal body functions, their limitations as drug candidates have been well documented. To overcome those limits, Peptor is using combinatorial chemistry to develop anti-inflammatory drugs based on its SCAPL platform technology.